1.09
price up icon0.93%   0.01
after-market Handel nachbörslich: 1.10 0.01 +0.92%
loading

Finanzdaten der Renovorx Inc-Aktie (RNXT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
162.14%
0.27
0.103 0.043 - -
Operating Expenses
8.25%
2.948
3.213 2.675 2.828 3.034
Benefits Costs and Expenses
25.45%
3.165
2.523 - - -
Costs And Expenses
8.25%
2.948
3.213 - - -
Operating Income/Loss
13.89%
-2.678
-3.11 -2.632 -2.828 -3.034
Nonoperating Income/Loss
131.45%
-0.217
0.69 -0.246 0.357 0.645
Income/Loss From Continuing Operations Before Tax
19.63%
-2.895
-2.42 -2.878 -2.471 -2.389
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.63%
-2.895
-2.42 -2.878 -2.471 -2.389
Net Income/Loss
19.63%
-2.895
-2.42 -2.878 -2.471 -2.389
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.50%
36.58
31.40 0.9455 24.94 24.05
Diluted Average Shares
16.50%
36.58
31.40 0.9455 24.94 24.05
Basic Earnings Per Share
0.00%
-0.08
-0.08 -0.12 -0.10 -0.10
Diluted Earnings Per Share
0.00%
-0.08
-0.08 -0.12 -0.10 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):